Summaries of the Section H (HML) update
Each month we issue a summary of the HML update. The table on this page gives a preview of the upcoming changes.
The table on this page gives a preview of the upcoming changes that will be announced in next month’s Section H of the Pharmaceutical Schedule.
The changes will be published in the Online HML(external link) around the 23rd of this month and are effective from next month.
For any questions about these listing changes or the Pharmaceutical Schedule in general, email us at enquiry@pharmac.govt.nz.
16 August 2024 – preview of changes for September 2024
Pharmaceutical |
Change |
---|---|
Acarbose (Accarb) tab 50 mg and 100 mg |
price increase and addition of PSS |
Aciclovir (ViruPOS) eye oint 3%, 4.5 g |
price increase and addition of PSS |
Aciclovir (Aciclovir-Baxter) inj 250 mg vial |
price increase and addition of PSS |
Amino acid formula (without phenylalanine) (PKU Start) powder (Neutral), 14.3 g protein, 25 g fat per 100 g, 400 g can, 4 can pack |
new listing (p’code 2689391) |
Amino acid formula (without phenylalanine) (PKU Start) powder (Neutral), 14.3 g protein, 25 g fat per 100 g, can , single can pack |
delisted 1 September 2024 |
Atenolol tab 50 mg (Viatris) and tab 100 mg (Atenolol Viatris) |
price increase and addition of PSS |
Atropine sulphate (Martindale) inj 600 mcg per ml, 1 ml ampoule |
price increase and addition of PSS |
Barium sulphate (Varibar – Honey and Pudding) oral liq 400 mg per ml (40% w/v), bottle |
price increase |
Barium sulphate |
new listing
|
Barium sulphate
|
delisted 1 September 2024 |
Barium sulphate with sodium bicarbonate (E-Z-Gas II) grans eff 382.2 mg per g with sodium bicarbonate 551.3 mg per g, 4 g sachet |
price decrease |
Betamethasone valerate crm 0.1%, 50 g (Beta Cream), oint 0.1%, 50 g (Beta Ointment) and scalp app 0.1%, 100 ml (Beta Scalp) |
price increase and addition of PSS |
Bisacodyl (Lax-Suppositories) suppos 10 mg |
price increase and addition of PSS |
Budesonide (SteroClear) nasal spray 50 mcg and 100 mcg per dose, 200 dose |
price decrease and addition of PSS |
Candesartan cilexetil (Candestar) tab 4 mg, 8 mg and 16 mg |
price increase and addition of PSS |
Candesartan cilexetil (Candestar) tab 32 mg |
price decrease and addition of PSS |
Carbomer (Poly Gel) ophthalmic gel 0.3%, single dose |
to be delisted 1 July 2025 |
Carmustine (Novadoz) inj 100 mg vial |
new listing (p’code 2689375) |
Cetomacrogol (Cetomacrogol-AFT) crm BP, 500 g |
price increase and addition of PSS |
Clonidine hydrochloride (Catapres) tab 150 mcg |
price increase and addition of PSS |
Crotamiton (Itch-Soothe) crm 10%, 20 g |
price increase and addition of PSS |
Cyclizine hydrochloride (Nausicalm) tab 50 mg |
price increase and addition of PSS |
Cyclophosphamide (Endoxan) inj 1 g and 2 g vial |
price increase and addition of PSS |
Dexamethasone (Dexmethsone) tab 0.5 mg and 4 mg |
price increase and addition of PSS |
Diclofenac sodium (Diclofenac Sandoz) tab EC 25 mg and 50 mg |
price increase and addition of PSS
|
Diphtheria, tetanus, pertussis, polio, hepatitis B and haemophilus influenzae type B vaccine (Infanrix-hexa) inj 30IU diphtheria with 40IU tetanus and 25mcg pertussis toxoids, 25mcg pertussis filamentous haemagglutinin, 8mcg pertactin, 80D-AgU polio virus, 10mcg hepatitis B antigen, 10mcg H. influenzae type b with tetanus toxoid 20-40mcg in 0.5ml syringe |
amended restriction criteria |
Dopamine hydrochloride (Max Health Ltd) inj 40 mg per ml, 5 ml ampoule |
price increase and addition of PSS |
Dorzolamide with timolol (Dortimopt) eye drops 2% with timolol 0.5%, 5 ml |
price increase and addition of PSS |
Enoxaparin sodium
|
price decrease and addition of PSS |
Felodipine tab long-acting 2.5 mg (Plendil ER), tab long-acting 5 mg (Felo 5 ER) and tab long-acting 10 mg (Felo 10 ER) |
price increase and addition of PSS |
Fentanyl (Biomed Fentanyl) inj 10 mcg per ml, 10 ml syringe |
new listing and addition of PSS (p’code 2670690) |
Fentanyl (Biomed) inj 20 mcg per ml, 50 ml |
addition of PSS |
Ferrous fumarate (Ferro-tab) tab 200 mg |
price increase and addition of PSS |
Flucloxacillin (AFT) grans for oral liq 25 mg and 50 mg per ml, 100 ml |
price increase and addition of PSS |
Flucloxacillin (AFT) grans for oral liq 25 mg and 50 mg per ml, 100 ml |
Pharmacodes 2072270 and 2072262 delisted 1 September 2024 |
Furosemide [frusemide] (IPCA-Frusemide) tab 40 mg |
price increase and addition of PSS |
Gadobenic acid (Multihance) inj 334 mg per ml, 10 ml and 20 ml vial |
delisted 1 September 2024 |
Hydrocortisone with miconazole (Micreme H) crm 1% with miconazole nitrate, 15 g |
price increase and addition of PSS |
Intra-uterine device (TCu 380 Plus Normal) IUD 33.6 mm length × 29.9 mm width |
new listing (p’code 2688484) |
Isoniazid (Isoniazid Teva) tab 100 mg |
new listing (p’code 2689294) |
Isoniazid with rifampicin (Rifinah) tab 100 mg with rifampicin 150 mg and tab 150 mg with rifampicin 300 mg |
addition of PSS |
Lansoprazole (Lanzol Relief) cap 15 mg |
price decrease and addition of PSS |
Lansoprazole (Lanzol Relief) cap 30 mg |
price increase and addition of PSS |
Levodopa with carbidopa
|
price increase and addition of PSS |
Lithium carbonate (Priadel) tab long-acting 400 mg |
price increase and addition of PSS |
Lopinavir with ritonavir (Lopinavir/Ritonavir Mylan) tab 200 mg with ritonavir 50 mg |
price increase and addition of PSS |
Lorazepam (Ativan) tab 1 mg and 2.5 mg |
price increase and addition of PSS |
Low-calcium formula (Locasol) powder 14.8 g protein, 53.7 g carbohydrate and 26.7 g fat per 100 g and tuna fish oil (DHA), can |
new listing (p’code 2684721) |
Low-calcium formula (Locasol) powder 14.6 g protein, 55.2 g carbohydrate and 25.8 g fat per 100 g, can |
to be delisted 1 March 2025 |
Macrogol 3350 with potassium chloride and sodium chloride (Glycoprep Orange) powder for oral soln 755.68 mg with potassium chloride 10.55 mg, sodium chloride 37.33 mg and sodium sulphate 80.62 mg per g, 70 g sachet, 3 and 12 pack |
price increase and addition of PSS |
Methadone hydrochloride
|
price increase and addition of PSS |
Methotrexate (Methotrexate Sandoz) inj 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg and 30 mg prefilled syringe |
price increase and addition of PSS |
Miconazole (Decozol) oral gel 20 mg per g, 40 g |
price increase and addition of PSS |
Midodrine (Midodrine Medsurge) tab 2.5 mg and 5 mg |
price decrease and addition of PSS |
Midodrine (MAR-Midodrine) tab 2.5 mg and 5 mg |
price decrease |
Moclobemide (Aurorix) tab 150 mg and 300 mg |
price increase and addition of PSS |
Mometasone furoate
|
price increase and addition of PSS |
Naltrexone hydrochloride (Revia) tab 50 mg |
new listing (p’code 2689049) |
Naproxen tab 250 mg (Noflam 250), tab 500 mg (Noflam 500), tab long-acting 750 mg (Naprosyn SR 750) and tab long-acting 1 g (Naprosyn SR 1000) |
price increase and addition of PSS |
Naproxen tab 250 mg (Noflam 250), tab 500 mg (Noflam 500) |
Pharmacodes 319333 and 323071 delisted 1 September 2024 |
Neostigmine metilsulfate (Max Health) inj 2.5 mg per ml, 1 ml ampoule |
price increase and addition of PSS |
Nevirapine (Nevirapine Viatris) tab 200 mg |
price increase and addition of PSS |
Norethisterone (Norethinderone - CDC) tab 350 mcg |
new listing (p’code 2685051) |
Orphenadrine citrate (Norflex) tab 100 mg |
price increase and addition of PSS |
Oxycodone hydrochloride (OxyNorm) cap immediate-release 10 mg and oral liq 5 mg per 5 ml |
to be delisted 1 October 2024 |
Oxycodone hydrochloride (OxyNorm) cap immediate-release 20 mg |
to be delisted 1 March 2025 |
Oxycodone hydrochloride (OxyNorm) cap immediate-release 5 mg |
to be delisted 1 December 2024 |
Pegaspargase (Oncaspar LYO) inj 750 iu per ml, 5 ml vial |
price increase |
Phenoxymethylpenicillin (penicillin V) (Cilicaine VK) cap 250 mg and 500 mg |
price increase and addition of PSS |
Pneumococcal (PCV10) conjugate vaccine (Synflorix) inj 1 mcg of pneumococcal polysaccharide serotypes 1, 5, 6B, 7F, 9V, 14 and 23F; 3 mcg of pneumococcal polysaccharide serotypes 4, 18C and 19F in 0.5 ml prefilled syringe |
delisted 1 September 2024 |
Prednisolone sodium (Essential Prednisolone) rectal foam 20 mg per dose (14 applications) |
to be delisted from 1 October 2024 |
Quinapril with hydrochlorothiazide tab 10 mg with hydrochlorothiazide 12.5 mg (Accuretic 10) and tab 20 mg with hydrochlorothiazide 12.5 mg (Accuretic 20) |
delisted 1 September 2024 |
Ramipril (Tryzan) cap 1.25 mg, 2.5 mg, 5 mg and 10 mg |
price increase and addition of PSS |
Riluzole (Rilutek) tab 50 mg |
price decrease and addition of PSS |
Risperidone (Risperdal) tab 1 mg and 3 mg |
new listing
|
Sodium fusidate [fusidic acid] (Foban) crm 2% and oint 2%, 5 g |
price increase and addition of PSS |
Somatropin (Omnitrope) inj 5 mg and 10 mg cartridge |
price increase and addition of PSS |
Somatropin (Omnitrope) inj 15 mg cartridge |
addition of PSS |
Temozolomide (Temozolomide-Taro) cap 5 mg |
new listing (p’code 2689413) |
Terlipressin inj 1 mg per 8.5 ml ampoule |
Brand change
|
Tretinoin (ReTrieve) crm 0.05%, 50 g |
price increase and addition of PSS |
Trimethoprim (TMP) tab 300 mg |
price increase and addition of PSS |
Trimethoprim with sulphamethoxazole [co-trimoxazole] (Trisul) tab trimethoprim 80 mg and sulphamethoxazole 400 mg |
price increase and addition of PSS |
Valaciclovir (Vaclovir) tab 500 mg and 1,000 mg |
price increase and addition of PSS |
Valganciclovir (Valganciclovir Viatris) tab 450 mg |
price increase and addition of PSS |
Vecuronium bromide (Vecure) inj 10 mg vial |
new listing and addition of PSS (p’code 2503379) |
Vincristine sulphate (DBL Vincristine Sulfate) inj 1 mg per ml, 1 ml vial |
price increase |
Zopiclone (Zopiclone Actavis) tab 7.5 mg, 500 tab pack |
new listing and addition of PSS (p’code 2480662) |